Effects of DOACs on Mouse Melanoma Metastasis and the Inhibitory Mechanism of Edoxaban, a Factor Xa-Specific DOAC. [PDF]
Hiramoto K +3 more
europepmc +1 more source
Incidence and outcomes of major bleeding among first-time oral factor Xa inhibitor users: multinational observational cohort studies. [PDF]
Cohen AT +20 more
europepmc +1 more source
Andexanet alfa vs standard of care for factor Xa inhibitor-induced intracranial hemorrhage-a systematic review and meta-analysis. [PDF]
Xiang AJ +7 more
europepmc +1 more source
Position statement of the Polish Society of Gastroenterology on the use of andexanet alfa in patients with gastrointestinal bleeding taking factor Xa inhibitors. [PDF]
Adrych K +4 more
europepmc +1 more source
Efficacy of pro-haemostatic agents in the management of factor Xa inhibitor-associated intracranial haemorrhages. [PDF]
Ng SS, Noori H, Nguyen D, Wang Z, Hsu D.
europepmc +1 more source
Detrimental Effect of Plasma From Patients With Severe Aortic Stenosis on Valvular Endothelial Cells: Role of Proinflammatory Cytokines and Factor Xa. [PDF]
Trimaille A +14 more
europepmc +1 more source
Peak and Trough Concentration Ranges of Factor Xa Inhibitors for Preventing Thromboembolic Stroke in Korean Patients with Non-valvular Atrial Fibrillation. [PDF]
Park JS +5 more
europepmc +1 more source
Development of an Electrochemical Immunosensor for Detecting Coagulation Factor Xa and Perspectives in Monitoring Direct Oral Anticoagulant Therapy. [PDF]
Meireles MR +5 more
europepmc +1 more source

